#innovationIOWA KemPharm Enhances U.S. and Global IP

CORALVILLE, Iowa, Oct. 13, 2015 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced several enhancements to KemPharm’s U.S. and global intellectual property estate governing its portfolio of prodrug product candidates.

For more information visit: http://investors.kempharm.com/phoenix.zhtml?c=253970&p=irol-newsArticle&ID=2096412

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s